Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613

Watchlist Manager
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd Logo
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613
Watchlist
Price: 6.39 CNY 0.79% Market Closed
Market Cap: ¥3.4B

Operating Margin

4.6%
Current
Improving
by 0.5%
vs 3-y average of 4.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
4.6%
=
Operating Income
¥86.6m
/
Revenue
¥1.9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
4.6%
=
Operating Income
¥86.6m
/
Revenue
¥1.9B

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613
3.4B CNY
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...

Market Distribution

In line with most companies in China
Percentile
52st
Based on 8 544 companies
52st percentile
4.6%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
Glance View

Market Cap
3.4B CNY
Industry
Pharmaceuticals

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. engages in the research and development, manufacture, and sale of antitumor, cardiovascular, cold and cough, children medicine, and anti fungi drugs. The company is headquartered in Shanghai, Shanghai and currently employs 1,371 full-time employees. is a China-based company principally engaged in research and development, manufacture and sale of pharmaceuticals. The Company’s products are targeted for the treatment of influenza, cardio cerebrovascular diseases, rheumatoid bone diseases and in the areas of oncology, antifungal, antipyretic and gynaecology. The firm's main products include cantharidin sodium vitamin B6 injection, cantharidin sodium injection and other Chinese patent drug products. The firm distributes its products in domestic market.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
4.6%
=
Operating Income
¥86.6m
/
Revenue
¥1.9B
What is Shanghai Shenqi Pharmaceutical Investment Management Co Ltd's current Operating Margin?

The current Operating Margin for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd is 4.6%, which is above its 3-year median of 4.1%.

How has Operating Margin changed over time?

Over the last 3 years, Shanghai Shenqi Pharmaceutical Investment Management Co Ltd’s Operating Margin has decreased from 5.1% to 4.6%. During this period, it reached a low of 3.5% on Sep 30, 2024 and a high of 6.2% on Dec 31, 2023.

Back to Top